Home › Funds › ADAR1 Capital Management, LLC › CYTK
ADAR1 Capital Management, LLC position in CYTK
CYTOKINETICS INC · Health Care
ADAR1 Capital Management, LLC reported holding 457,907 shares of CYTK (CYTOKINETICS INC) in its Q2 2026 13F filing — a position valued at US$39.0M, representing 2.16% of its reported portfolio and ranking #8 among its reported holdings. ADAR1 Capital Management, LLC has disclosed CYTK holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ADAR1 Capital Management, LLC's CYTK position evolved
ADAR1 Capital Management, LLC first disclosed a stake in CYTK in Q4 2023 at 3,500 shares (US$292K). The position peaked in Q1 2026 at 632,556 shares, worth US$41.7M. Across 11 filings, ADAR1 Capital Management, LLC increased the stake 5 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 457,907 shares valued at US$39.0M — a reduction of -174,649 shares quarter over quarter.. Notable position changes include a 96% trim in Q2 2024 (shares fell 3% over the following quarter), a 15000% increase in Q3 2024 (shares fell 11% over the following quarter), a 2488% increase in Q1 2025 (shares fell 18% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 3.50K | $292.21K | New |
| Q1 2024 | 2.50K | $175.28K | Reduce |
| Q2 2024 | 100 | $5.42K | Reduce |
| Q3 2024 | 15.10K | $797.28K | Add |
| Q4 2024 | 15.10K | $710.30K | Hold |
| Q1 2025 | 390.73K | $15.70M | Add |
| Q2 2025 | 582.15K | $19.23M | Add |
| Q3 2025 | 518.92K | $28.52M | Reduce |
| Q4 2025 | 540.17K | $34.32M | Add |
| Q1 2026 | 632.56K | $41.69M | Add |
| Q2 2026 | 457.91K | $39.01M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CYTK and 13F data
CYTK (CYTOKINETICS INC) is a Health Care company. 52 other funds we track also report a position in CYTK — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.59B), Avoro Capital Advisors LLC (US$425.9M), RTW INVESTMENTS, LP (US$243.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CYTK
- T. Rowe Price Investment Management, Inc. 18.72M sh · $1.59B · Q2 2026
- Avoro Capital Advisors LLC 5.00M sh · $425.95M · Q2 2026
- RTW INVESTMENTS, LP 2.86M sh · $243.81M · Q2 2026
- Polar Capital Holdings Plc 2.25M sh · $191.99M · Q2 2026
- Integral Health Asset Management, LLC 1.60M sh · $136.30M · Q2 2026
- ARMISTICE CAPITAL, LLC 1.20M sh · $102.34M · Q2 2026
- Frazier Life Sciences Management, L.P. 1.16M sh · $98.81M · Q2 2026
- Royalty Pharma Sub-Manager, LLC 980.39K sh · $83.52M · Q2 2026
- GW&K Investment Management, LLC 916.11K sh · $78.04M · Q2 2026
- Melqart Asset Management (UK) Ltd 767.52K sh · $65.39M · Q2 2026
- Siren, L.L.C. 758.95K sh · $64.66M · Q2 2026
- Foresite Capital Management IV, LLC 714.70K sh · $60.88M · Q2 2026
More on ADAR1 Capital Management, LLC
FAQ
How long has ADAR1 Capital Management, LLC held CYTK?
ADAR1 Capital Management, LLC has disclosed CYTK holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
What is ADAR1 Capital Management, LLC's current position in CYTK?
As of Q2 2026, ADAR1 Capital Management, LLC holds 457.91K shares of CYTK (CYTOKINETICS INC), valued at $39.01M, representing 2.16% of its reported portfolio and ranking #8.
Has ADAR1 Capital Management, LLC been buying or selling CYTK?
In the latest 13F filing (Q2 2026), ADAR1 Capital Management, LLC reduced its position in CYTK. The position peaked in Q1 2026 at 632.56K shares.
Which other funds hold CYTK?
Other major institutional holders of CYTK include T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, RTW INVESTMENTS, LP, among 52 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.